TC BioPharm (Holdings) (FRA:T0U) Moat Score: 0/10 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:T0U TC BioPharm (Holdings) PLC FRA:T0U
17 GF Score
Price €132.00
View Full Analysis

What is TC BioPharm (Holdings) Moat Score?

TC BioPharm (Holdings) has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

TC BioPharm (Holdings) has Narrow Moat: TC BioPharm has a solid narrow moat due to its valuable intellectual property and R&D capabilities in the biotech sector. However, it lacks the scale and market dominance required for a wide moat, and its competitive advantages are not yet robust enough to be considered durable.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes TC BioPharm (Holdings) might have No Moat - No discernible moat.

TC BioPharm (Holdings)  (FRA:T0U) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

TC BioPharm (Holdings) Moat Score Related Terms

FRA:T0U
17GF Score
TC BioPharm (Holdings) PLC FRA:T0U
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TC BioPharm (Holdings) Business Description

Address Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
17GF Score

Get the complete analysis for FRA:T0U

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€132.00
Price